TY - JOUR
T1 - The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism
AU - Deora, Aparna
AU - Spearman, Paul
AU - Ratner, Lee
N1 - Funding Information:
We thank Dr. Ruili Gu and Mr. Robert Horton, respectively, for constructing pTM-Vpu and pTM-MA; and Dr. K. Ponder for the kind gift of hAAT plasmids and antibodies. This work was supported by PHS Grant AI34736 and training Grant 5 T32 HL 07088-23 (A.D.).
PY - 2000/4/10
Y1 - 2000/4/10
N2 - Viral protein U (Vpu) is an 81 amino acid phosphoprotein found in human immunodeficiency virus type 1 (HIV-1)-infected cells. One function of Vpu is to enhance the release of virus particles from the plasma membrane in infected cells. Using subcellular fractionation, we observed that Vpu promotes the targeting of Pr55 Gag to the plasma membrane, the site of viral assembly. Deletions of Pr55, which removed most of the N-terminal matrix domain (p39) or the C-terminal domains of nucleocapsid and p6 (p4i), still allowed for virus-like particle production. Moreover, the release of these particles remained Vpu-responsive. The N-terminal matrix (MA) domain of Gag, which contains its membrane-binding domain, is sufficient for Vpu-mediated enhanced release into the supernatant. Furthermore, a MA-GFP fusion protein showed enhanced membrane binding in the presence of Vpu. This demonstrates that Vpu action may be mediated by allowing Gag, specifically the N-terminal matrix domain, to efficiently associate with the plasma membrane. Thus MA appears sufficient but not necessary for Vpu-mediated enhanced particle release. (C) 2000 Academic Press.
AB - Viral protein U (Vpu) is an 81 amino acid phosphoprotein found in human immunodeficiency virus type 1 (HIV-1)-infected cells. One function of Vpu is to enhance the release of virus particles from the plasma membrane in infected cells. Using subcellular fractionation, we observed that Vpu promotes the targeting of Pr55 Gag to the plasma membrane, the site of viral assembly. Deletions of Pr55, which removed most of the N-terminal matrix domain (p39) or the C-terminal domains of nucleocapsid and p6 (p4i), still allowed for virus-like particle production. Moreover, the release of these particles remained Vpu-responsive. The N-terminal matrix (MA) domain of Gag, which contains its membrane-binding domain, is sufficient for Vpu-mediated enhanced release into the supernatant. Furthermore, a MA-GFP fusion protein showed enhanced membrane binding in the presence of Vpu. This demonstrates that Vpu action may be mediated by allowing Gag, specifically the N-terminal matrix domain, to efficiently associate with the plasma membrane. Thus MA appears sufficient but not necessary for Vpu-mediated enhanced particle release. (C) 2000 Academic Press.
KW - HIV-1 Gag
KW - Matrix
KW - Membrane
KW - Vpu
UR - http://www.scopus.com/inward/record.url?scp=0034629752&partnerID=8YFLogxK
U2 - 10.1006/viro.1999.0094
DO - 10.1006/viro.1999.0094
M3 - Article
C2 - 10753709
AN - SCOPUS:0034629752
SN - 0042-6822
VL - 269
SP - 305
EP - 312
JO - Virology
JF - Virology
IS - 2
ER -